Long-Term Safety of Tocilizumab in Patients with Rheumatoid Arthritis and a Mean Treatment Duration of 3.7 Years.

被引：0
|
作者：
Genovese, Mark C. [1 ]
Sebba, Anthony [2 ]
Rubbert-Roth, Andrea [3 ]
Jose Scali, Juan [4 ]
Alten, Rieke [5 ]
Kremer, Joel M. [6 ]
Pitts, Laura [7 ]
Vernon, Emma [7 ]
van Vollenhoven, Ronald F. [8 ]
机构：
[1] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA
[2] Univ S Florida, Tampa, FL USA
[3] Univ Cologne, D-50931 Cologne, Germany
[4] Durand Univ Hosp, Buenos Aires, DF, Argentina
[5] Univ Med Berlin, Schlosspk Klin, Berlin, Germany
[6] Albany Med Coll, Albany, NY 12208 USA
[7] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England
[8] Karolinska Inst, Stockholm, Sweden
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1640
引用
收藏
页码：S700 / S701
页数：2
相关论文
共 50 条
  • [21] Long-Term Safety of Tocilizumab in Rheumatoid Arthritis Clinical Trials.
    Genovese, Mark C.
    Sebba, Anthony
    Rubbert-Roth, Andrea
    Scali, Juan
    Zilberstein, Moshe
    Thompson, Liz
    van Vollenhoven, Ronald F.
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S866 - S866
  • [22] SAFETY AND TOLERABILITY OF TOCILIZUMAB IN LONG-TERM EXTENSION STUDIES OF RHEUMATOID ARTHRITIS
    Nash, P.
    Taylor, A.
    Hall, S.
    Jones, G.
    Youssef, P.
    Genovese, M.
    [J]. INTERNAL MEDICINE JOURNAL, 2011, 41 : 17 - 17
  • [23] Safety Analysis of Tocilizumab (TCZ) in Rheumatoid Arthritis (RA) Patients (pts): Long-Term Extension Studies (Median of 3.1 Years of Treatment)
    van Vollenhoven, Ronald
    Cividino, Alfred
    Jose Scali, Juan
    Curtis, Jeffrey
    Krasnow, Joel
    Vernon, Emma
    Alten, Rieke
    [J]. JOURNAL OF RHEUMATOLOGY, 2011, 38 (06) : 1164 - 1164
  • [24] The efficacy and safety of reinstitution of tocilizumab in patients with relapsed active rheumatoid arthritis after long-term withdrawal of tocilizumab
    Sagawa, Akira
    [J]. MODERN RHEUMATOLOGY, 2011, 21 (04) : 352 - 358
  • [25] Lipids and Atherogenic Indices Fluctuation in Rheumatoid Arthritis Patients on Long-Term Tocilizumab Treatment
    Cacciapaglia, Fabio
    Anelli, Maria Grazia
    Rinaldi, Angela
    Fornaro, Marco
    Lopalco, Giuseppe
    Scioscia, Crescenzio
    Lapadula, Giovanni
    Iannone, Florenzo
    [J]. MEDIATORS OF INFLAMMATION, 2018, 2018
  • [26] Long-term Efficacy of Tocilizumab in Rheumatoid Arthritis (RA) for up to 3.5 Years
    Smolen, J.
    Khraishi, Majed
    Gomez-reino, Juan
    [J]. JOURNAL OF RHEUMATOLOGY, 2010, 37 (06) : 1334 - 1334
  • [27] Long term treatment with sulphasalazine in rheumatoid arthritis (RA): 351 patients followed for 10 years.
    Duncan, MR
    Crosbie, D
    Thomson, EA
    Hunter, JA
    Porter, DR
    Hampson, R
    Madhok, R
    Capell, HA
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S144 - S144
  • [28] LONG-TERM EFFICACY OF TOCILIZUMAB UP TO 3.5 YEARS IN PATIENTS WITH RHEUMATOID ARTHRITIS: AN INTERIM ANALYSIS OF LONG-TERM EXTENSION STUDIES
    Calvo, A.
    Sid, D.
    Saavedra, M.
    Kissel, K.
    Alecock, E.
    Smolen, J.
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S34 - S34
  • [29] Long-term safety of methotrexate in the treatment of rheumatoid arthritis
    Yazici, Y.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (05) : S65 - S67
  • [30] Long-term Safety of Rituximab in the Treatment of rheumatoid Arthritis
    Hoefler-Speckner, Simone
    [J]. JOURNAL FUR MINERALSTOFFWECHSEL, 2011, 18 (02): : 92 - 92
12345